Literature DB >> 17024146

Does growth hormone therapy increase the risk of cancer?

Anthony J Swerdlow1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 17024146     DOI： 10.1038/ncpendmet0295

Source DB:  PubMed          Journal:  Nat Clin Pract Endocrinol Metab        ISSN： 1745-8366


× No keyword cloud information.
  6 in total

1.  Long-term safety and efficacy of Omnitrope®, a somatropin biosimilar, in children requiring growth hormone treatment: Italian interim analysis of the PATRO Children study.

Authors:  Lorenzo Iughetti; Gianluca Tornese; Maria Elisabeth Street; Flavia Napoli; Claudia Giavoli; Franco Antoniazzi; Stefano Stagi; Caterina Luongo; Sara Azzolini; Letizia Ragusa; Gianni Bona; Clara Zecchino; Tommaso Aversa; Luca Persani; Laura Guazzarotti; Emiliano Zecchi; Alberto Pietropoli; Stefano Zucchini
Journal:  Ital J Pediatr       Date:  2016-11-03       Impact factor: 2.638

2.  Risk of Meningioma in European Patients Treated With Growth Hormone in Childhood: Results From the SAGhE Cohort.

Authors:  Anthony J Swerdlow; Rosie Cooke; Dominique Beckers; Gary Butler; Jean-Claude Carel; Stefano Cianfarani; Peter Clayton; Joël Coste; Annalisa Deodati; Emmanuel Ecosse; Anita C S Hokken-Koelega; Aysha J Khan; Wieland Kiess; Claudia E Kuehni; Christa E Flück; Roland Pfaffle; Lars Sävendahl; Grit Sommer; Muriel Thomas; Anders Tidblad; Sally Tollerfield; Gladys R J Zandwijken
Journal:  J Clin Endocrinol Metab       Date:  2019-03-01       Impact factor: 5.958

3.  The Proteomic Signature of Recombinant Growth Hormone in Recreational Athletes.

Authors:  Max Esefeld; Antoni Pastor; Rafael de la Torre; Osquel Barroso; Reid Aikin; Hina Sarwath; Rudolf Engelke; Frank Schmidt; Karsten Suhre
Journal:  J Endocr Soc       Date:  2021-11-02

4.  Cancer Risks in Patients Treated With Growth Hormone in Childhood: The SAGhE European Cohort Study.

Authors:  Anthony J Swerdlow; Rosie Cooke; Dominique Beckers; Birgit Borgström; Gary Butler; Jean-Claude Carel; Stefano Cianfarani; Peter Clayton; Joël Coste; Annalisa Deodati; Emmanuel Ecosse; Ruth Gausche; Claudio Giacomozzi; Anita C S Hokken-Koelega; Aysha J Khan; Wieland Kiess; Claudia E Kuehni; Primus-E Mullis; Roland Pfaffle; Lars Sävendahl; Grit Sommer; Muriel Thomas; Anders Tidblad; Sally Tollerfield; Liesbet Van Eycken; Gladys R J Zandwijken
Journal:  J Clin Endocrinol Metab       Date:  2017-05-01       Impact factor: 5.958

5.  Description of the SAGhE Cohort: A Large European Study of Mortality and Cancer Incidence Risks after Childhood Treatment with Recombinant Growth Hormone.

Authors:  Anthony J Swerdlow; Rosie Cooke; Kerstin Albertsson-Wikland; Birgit Borgström; Gary Butler; Stefano Cianfarani; Peter Clayton; Joël Coste; Annalisa Deodati; Emmanuel Ecosse; Ruth Gausche; Claudio Giacomozzi; Wieland Kiess; Anita C S Hokken-Koelega; Claudia E Kuehni; Fabienne Landier; Marc Maes; Primus-E Mullis; Roland Pfaffle; Lars Sävendahl; Grit Sommer; Muriel Thomas; Sally Tollerfield; Gladys R J Zandwijken; Jean-Claude Carel
Journal:  Horm Res Paediatr       Date:  2015-07-23       Impact factor: 2.852

6.  Increased risk of bone tumors after growth hormone treatment in childhood: A population-based cohort study in France.

Authors:  Amélie Poidvin; Jean-Claude Carel; Emmanuel Ecosse; Dominique Levy; Jean Michon; Joël Coste
Journal:  Cancer Med       Date:  2018-06-14       Impact factor: 4.452
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.